Delivery Order SPE2DE24D0021-SPE2D625F6YF7
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,346.48 on September 26, 2025, for the MAGMAX VIRAL/PATHOGEN product line, with an ultimate completion date of October 20, 2025. This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, and is funded through the Defense Department's Medical Supply Chain division. The contract was awarded without any set-aside designation, indicating open competition. As a child contract,...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order contract valued at $1,173.24 by the Medical Supply Chain division of the Department of Defense on September 9, 2025, for MAGMAX viral/pathogen supplies. The contract is classified as a child award under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 30, 2025. No small business set-aside was utilized for this procurement, indicating the award was made...
- Fisher Scientific Company L.L.C. was awarded a $5,279.58 fixed-price delivery order (Contract No. 4569344230) for MAGMAX Viral/Pathogen supplies by the Medical Supply Chain, a defense-focused federal agency. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was issued through open competition with no set-aside designation,...
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 22, 2025, for the procurement of 5X MAGMAX Pathogen RNA/DNA Kits with a ceiling value of $3,091.01. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of July 29, 2025. The contract will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense agency to Fisher Scientific Company L.L.C., doing business as Fisher Scientific. The $2,244.00 fixed-price contract is for the delivery of MAGMAX VIRAL/PATHOGEN products, with a completion date of November 27, 2024. The contract does not have a set-aside designation. Fisher Scientific is a major supplier of scientific products, equipment, and services to federal agencies, including the Department of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,433.64 for DNA extraction and purification products utilizing the MagMAX technology platform. The contract, issued by the Defense Medical Supply Chain on August 6, 2025, represents a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by August 13, 2025. The work will be performed in Pittsburgh, Pennsylvania. This delivery order is issued under a larger contract vehicle and...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $34,334.30 by the Medical Supply Chain, a defense-focused federal agency, on June 16, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of process complex mass cytokine and channel 96 test supplies to support operations at the agency's Pittsburgh, Pennsylvania facility. The award was made through open competition with no set-aside designation,...
- Fisher Scientific Company L.L.C. received a $1,158.62 fixed-price delivery order from the Medical Supply Chain, a defense-oriented federal agency, with an award date of July 27, 2025 and ultimate completion date of July 30, 2025. The contract, which is classified as a child contract with no set-aside designation, calls for the delivery of sampler, PDL, HPC, TCNT, grid filter products to support San PE operations. The place of performance is Pittsburgh, Pennsylvania. This delivery order...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2,131.55 by the Medical Supply Chain, a defense-focused federal agency, on July 22, 2025. The contract, which carries an ultimate completion date of August 5, 2025, represents a child contract with no set-aside designation and will be performed in Pittsburgh, Pennsylvania. As a delivery order, this award likely represents a task issued under a larger indefinite-delivery/indefinite-quantity contract vehicle or...
- Fisher Scientific Company L.L.C., doing business as Fisher Scientific, has been awarded a $2,200.52 delivery order against the Defense Logistics Agency Troop Support Medical blanket purchase agreement to provide MAGMAX viral/pathogen detection kits. The delivery order was awarded on December 5, 2023 and is to be completed by December 27, 2023. No set-aside designation was used for this award. Fisher Scientific will deliver the requested products to the agency's location in Pittsburgh,...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F6YF7Delivery Order
Fisher Scientific Company L.L.C. has been awarded a $2,346.48 delivery order contract (Contract No. 4568797735) for MAGMAX Viral/Pathogen products by the Defense Department's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by August 5, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made on July 15, 2025, without any set-aside designation, reflecting Fisher Scientific's ability to compete effectively in open federal procurement. As a major supplier of laboratory supplies, scientific instruments, and specialized testing solutions, Fisher Scientific has an established track record supporting federal agencies including the National Institutes of Health, Department of Veterans Affairs, and various defense-related entities. This delivery order represents a child contract under a larger acquisition vehicle, likely leveraging Fisher Scientific's extensive capabilities in providing advanced laboratory and medical equipment to government agencies. The MAGMAX product line, focused on viral and pathogen-related testing supplies, aligns with the company's specialization in delivering specialized testing solutions and reagents across multiple scientific domains. The relatively modest ceiling value suggests this order addresses a specific, near-term operational requirement within the Medical Supply Chain's broader procurement strategy for viral and pathogen diagnostic support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/15/25 |